Modeling of Mycobacterium tuberculosis dormancy in bacterial cultures

Stewart, 2003, Tuberculosis: a problem with persistence, Nat Rev Microbiol, 1, 97, 10.1038/nrmicro749 Esmail, 2014, The ongoing challenge of latent tuberculosis, Philos Trans R Soc B Biol Sci, 369, 10.1098/rstb.2013.0437 Chao, 2010, Letting sleeping doslLie: does dormancy play a role in tuberculosis?, Annu Rev Microbiol, 64, 293, 10.1146/annurev.micro.112408.134043 Gengenbacher, 2012, Mycobacterium tuberculosis: success through dormancy, FEMS Microbiol Rev, 36, 514, 10.1111/j.1574-6976.2012.00331.x Lillebaek, 2002, Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection, J Infect Dis, 185, 401, 10.1086/338342 Millington, 2010, Mycobacterium tuberculosis–specific cellular immune profiles suggest bacillary persistence decades after spontaneous cure inuUntreated tuberculosis, J Infect Dis, 202, 1685, 10.1086/656772 Mayito, 2018, Anatomic and cellular niches for Mycobacterium tuberculosis in latent tuberculosis infection, J Infect Dis Horsburgh, 2004, Priorities for the treatment of latent tuberculosis infection in the United States, N Engl J Med, 350, 2060, 10.1056/NEJMsa031667 WHO, 2015, vol 38 Ai, 2016, Updates on the risk factors for latent tuberculosis reactivation and their managements, Emerg Microb Infect, 5, 10.1038/emi.2016.10 WHO, 2015 Shea, 2014, Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup, Am J Epidemiol, 179, 216, 10.1093/aje/kwt246 Houben, 2016, The gglobal burden of latent tuberculosis infection: a re-estimation using mathematical modelling, PLoS Med, 13, 10.1371/journal.pmed.1002152 Basera, 2017, Prevalence and risk factors of latent tuberculosis infection in Africa: a systematic review and meta-analysis protocol, BMJ Open, 7, 1, 10.1136/bmjopen-2016-012636 Van Rie, 2013, Prevalence, risk factors and risk perception of tuberculosis infection among medical students and healthcare workers in Johannesburg, South Africa, SAMJ (S Afr Med J), 103, 853, 10.7196/samj.7092 Yeon, 2018, Prevalence and risk factors of latent tuberculosis among Korean healthcare workers using whole-blood interferon-γ release assay, Sci Rep, 8, 8, 10.1038/s41598-018-28430-w López de Goicoechea-Saiz, 2018, Prevalence and associated risk factors of latent tuberculosis infection in a Spanish prison, Rev Española Sanid Penit, 20, 4 Jin, 2018, Prevalence of latent tuberculosis infection among coal workers' pneumoconiosis patients in China: a cross-sectional study, BMC Public Health, 18, 1, 10.1186/s12889-018-5373-1 Chandrasekaran, 2018, Tuberculin skin test and QuantiFERON-Gold in Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting, PLoS One, 13, 10.1371/journal.pone.0199360 Lillebaek, 2003, Stability of DNA patterns and evidence of Mycobacterium tuberculosis reactivation occurring decades after the initial infection, J Infect Dis, 188, 1032, 10.1086/378240 Verver, 2005, Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis, Am J Respir Crit Care Med, 171, 1430, 10.1164/rccm.200409-1200OC Feldman, 1938, The residual infectivity of the primary complex of tuberculosis, Am J Pathol, 14 Kwan, 2013, Arrested protein synthesis increases persister-like cell formation, Antimicrob Agents Chemother, 57, 1468, 10.1128/AAC.02135-12 Van den Bergh, 2017, Formation, physiology, ecology, evolution and clinical importance of bacterial persisters, FEMS Microbiol Rev, 41, 219, 10.1093/femsre/fux001 Rosser, 2018, Recurrent tuberculosis in the pre-elimination era, Int J Tuberc Lung Dis, 22, 139, 10.5588/ijtld.17.0590 Parvaresh, 2018, Recurrence of tuberculosis in a low-incidence setting: a retrospective cross-sectional study augmented by whole genome sequencing, BMC Infect Dis, 18, 4, 10.1186/s12879-018-3164-z Rosser, 2018, A nested case-control study of predictors for tuberculosis recurrence in a large UK centre, BMC Infect Dis, 18, 1, 10.1186/s12879-017-2933-4 Chen, 2017, Recurrence after successful treatment of multidrug-resistant tuberculosis in Taiwan, PLoS One, 12, 1 Mirsaeidi, 2018, Patients at high risk of tuberculosis recurrence, Int J Mycobacteriol, 7, 1, 10.4103/ijmy.ijmy_164_17 WHO, 2018 WHO, 2015 Kaprelyants, 1993, Dormancy in non-sporulating bacteria, FEMS Microbiol Lett, 104, 271, 10.1111/j.1574-6968.1993.tb05871.x Lipworth, 2016, Defining dormancy in mycobacterial disease, Tuberculosis, 99, 131, 10.1016/j.tube.2016.05.006 Zhang, 2004, Persisttent and dormant tubercle bacilli and latent tuberculosis, Front Biosci, 9, 1136, 10.2741/1291 Lahiri, 2018, Cultivation and viability determination of Mycobacterium leprae Davey, 2011, Life, death, and in-between: meanings and methods in microbiology, Appl Environ Microbiol, 77, 5571, 10.1128/AEM.00744-11 Soejima, 2009, Discrimination of live, anti-tuberculosis agent-injured, and dead Mycobacterium tuberculosis using flow cytometry, FEMS Microbiol Lett, 294, 74, 10.1111/j.1574-6968.2009.01549.x Cangelosi, 2014, Dead or alive: molecular assessment of microbial viability, Appl Environ Microbiol, 80, 5884, 10.1128/AEM.01763-14 Oliver, 2010, Recent findings on the viable but nonculturable state in pathogenic bacteria, FEMS Microbiol Rev, 34, 415, 10.1111/j.1574-6976.2009.00200.x Li, 2014, The importance of the viable but non-culturable state in human bacterial pathogens, Front Microbiol, 5, 1, 10.3389/fmicb.2014.00258 Manina, 2016, A Single-cell perspective on non-growing but metabolically active (NGMA) bacteria, vol 205 Murphy, 2007, Identification of gene targets against dormant phase Mycobacterium tuberculosis infections, BMC Infect Dis, 7, 10.1186/1471-2334-7-84 Salina, 2009, Tuberculosis gene expression during transition to the "non-culturable" state, Acta Naturae, 1, 73, 10.32607/20758251-2009-1-2-73-77 Aguilar-Ayala, 2017, The transcriptome of Mycobacterium tuberculosis in a lipid-rich dormancy model through RNAseq analysis, Sci Rep, 7, 1, 10.1038/s41598-017-17751-x Wang, 2011, Genes and regulatory networks involved in persistence of Mycobacterium tuberculosis, Sci China Life Sci, 54, 300, 10.1007/s11427-011-4134-5 Honaker, 2009, Unique roles of DosT and DosS in DosR regulon induction and Mycobacterium tuberculosis dormancy, Infect Immun, 77, 3258, 10.1128/IAI.01449-08 Chen, 2013, The Mycobacterium DosR regulon structure and diversity revealed by comparative genomic analysis, J Cell Biochem, 114, 1, 10.1002/jcb.24302 Minch, 2012, Mycobacterium tuberculosis growth following aerobic expression of the DosR regulon, PLoS One, 7, 2, 10.1371/journal.pone.0035935 Kumari, 2017, Sustained expression of DevR/DosR during long-term hypoxic culture of Mycobacterium tuberculosis, Tuberculosis, 106, 33, 10.1016/j.tube.2017.06.003 Haile, 2002, Expression of the mceA, esat-6 and hspX genes in Mycobacterium tuberculosis and their responses to aerobic conditions and to restricted oxygen supply, Microbiology, 148, 3881, 10.1099/00221287-148-12-3881 Iona, 2016, Mycobacterium tuberculosis gene expression at different stages of hypoxia-induced dormancy and upon resuscitation, J Microbiol, 54, 565, 10.1007/s12275-016-6150-4 Kim, 2008, Differentially expressed genes in Mycobacterium tuberculosis H37Rv under mild acidic and hypoxic conditions, J Med Microbiol, 57, 1473, 10.1099/jmm.0.2008/001545-0 Armstrong, 2016, Rv2744c is a PspA ortholog that regulates lipid droplet homeostasis and nonreplicating persistence in Mycobacterium tuberculosis, J Bacteriol, 198, 1645, 10.1128/JB.01001-15 Boshoff, 2005, Tuberculosis—metabolism and respiration in the absence of growth, Nat Rev Microbiol, 3, 70, 10.1038/nrmicro1065 Shi, 2010, Carbon flux rerouting during Mycobacterium tuberculosis growth arrest, Mol Microbiol, 78, 1199, 10.1111/j.1365-2958.2010.07399.x Ehrt, 2018, Metabolic principles of persistence and pathogenicity in Mycobacterium tuberculosis, Nat Rev Microbiol, 16, 496, 10.1038/s41579-018-0013-4 Gopinath, 2015, Profiling the proteome of Mycobacterium tuberculosis during dormancy and reactivation, Mol Cell Proteom, 14, 2160, 10.1074/mcp.M115.051151 Schubert, 2015, Absolute proteome composition and dynamics during dormancy and resuscitation of Mycobacterium tuberculosis, Cell Host Microbe, 18, 96, 10.1016/j.chom.2015.06.001 Wolfe, 2013, A chemical proteomics approach to profiling the ATP-binding proteome of Mycobacterium tuberculosis, Mol Cell Proteom, 12, 1644, 10.1074/mcp.M112.025635 Wayne, 1982, Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions, Infect Immun, 37, 1042, 10.1128/IAI.37.3.1042-1049.1982 Gould, 2006, Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis, Mol Microbiol, 61, 940, 10.1111/j.1365-2958.2006.05297.x Baker, 2018, Genetic and metabolic regulation of Mycobacterium tuberculosis acid growth arrest, Sci Rep, 8, 1, 10.1038/s41598-018-22343-4 McKinney, 2000, Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase, Nature, 406, 735, 10.1038/35021074 Watanabe, 2011, Fumarate reductase activity maintains an energized membrane in anaerobic Mycobacterium tuberculosis, PLoS Pathog, 7, 10.1371/journal.ppat.1002287 Leistikow, 2010, The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy, J Bacteriol, 192, 1662, 10.1128/JB.00926-09 Daniel, 2004, Induction of a novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a dormancy-like state in culture, J Bacteriol, 186, 5017, 10.1128/JB.186.15.5017-5030.2004 Eoh, 2017, Metabolic anticipation in Mycobacterium tuberculosis, Nat Microbiol, 2, 10.1038/nmicrobiol.2017.84 Wayne, 1998, Nitrate reduction as a marker for hypoxic shiftdown of Mycobacterium tuberculosis, Tuber Lung Dis, 79, 127, 10.1054/tuld.1998.0015 Sohaskey, 2008, Nitrate enhances the survival of Mycobacterium tuberculosis during inhibition of respiration, J Bacteriol, 190, 2981, 10.1128/JB.01857-07 Tan, 2010, Nitrate respiration protects hypoxic Mycobacterium tuberculosis against acid- and reactive nitrogen species stresses, PLoS One, 5, 1, 10.1371/journal.pone.0013356 Velayati, 2016, Populations of latent Mycobacterium tuberculosis lack a cell wall: isolation, visualization, and whole-genome characterization, Int J Mycobacteriol, 5, 66, 10.1016/j.ijmyco.2015.12.001 Rittershaus, 2013, The normalcy of dormancy: common themes in microbial quiescence, Cell Host Microbe, 10.1016/j.chom.2013.05.012 Shleeva, 2011, Dormant ovoid cells of Mycobacterium tuberculosis are formed in response to gradual external acidification, Tuberculosis, 91, 146, 10.1016/j.tube.2010.12.006 Daniel, 2011, Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages, PLoS Pathog, 7, 10.1371/journal.ppat.1002093 Kapoor, 2013, Human granuloma in vitro model, for TB dormancy and resuscitation, PLoS One, 8, 10.1371/journal.pone.0053657 Seiler, 2003, Cell‐wall alterations as an attribute of Mycobacterium tuberculosis in latent infection, J Infect Dis, 188, 1326, 10.1086/378563 Kester, 2014, Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria, Crit Rev Biochem Mol Biol, 49, 91, 10.3109/10409238.2013.869543 Wallis, 1999, Drug tolerance in Mycobacterium tuberculosis, Antimicrob Agents Chemother, 43, 2600, 10.1128/AAC.43.11.2600 Tudó, 2010, Examining the basis of isoniazid tolerance in nonreplicating Mycobacterium tuberculosis using transcriptional profiling, Future Med Chem, 2, 1371, 10.4155/fmc.10.219 Sarathy, 2018, Extreme drug tolerance of Mycobacterium tuberculosis in caseum, Antimicrob Agents Chemother, 62, 1, 10.1128/AAC.02266-17 Zhang, 1992, The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis, Nature, 358, 591, 10.1038/358591a0 Karakousis, 2008, Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis, J Antimicrob Chemother, 61, 323, 10.1093/jac/dkm485 Iacobino, 2017, Fighting tuberculosis by drugs targeting nonreplicating Mycobacterium tuberculosis bacilli, Int J Mycobacteriol, 6, 213, 10.4103/ijmy.ijmy_85_17 Liu, 2016, Impact of hypoxia on drug resistance and growth characteristics of Mycobacterium tuberculosis clinical isolates, PLoS One, 11, 1 Raghunandanan, 2018, Dormant Mycobacterium tuberculosis converts isoniazid to the active drug in a Wayne's model of dormancy, J Antibiot (Tokyo), 71, 939, 10.1038/s41429-018-0098-z Koul, 2008, Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis, J Biol Chem, 283, 25273, 10.1074/jbc.M803899200 Koul, 2014, Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism, Nat Commun, 5, 3369, 10.1038/ncomms4369 Lakshminarayana, 2015, Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents, J Antimicrob Chemother, 70, 857, 10.1093/jac/dku457 Bogosian, 2001, A matter of bacterial life and death, EMBO Rep, 2, 770, 10.1093/embo-reports/kve182 Dworkin, 2010, Exit from dormancy in microbial organisms, Nat Rev Microbiol, 8, 890, 10.1038/nrmicro2453 Du, 2016, Transcriptional and physiological changes during Mycobacterium tuberculosis reactivation from non-replicating persistence, Front Microbiol, 7, 10.3389/fmicb.2016.01346 Veatch, 2017, Opening pandora's box: mechanisms of Mycobacterium tuberculosis resuscitation, Trends Microbiol, 1491, 1 Loebel, 1933, The Influence of adverse conditions upon the respiratory metabolism and growth of human tubercle bacilli, J Bacteriol, 26, 167, 10.1128/JB.26.2.167-200.1933 Via, 2008, Tuberculous granulomas are hypoxic in Guinea pigs, rabbits, and nonhuman primates, Infect Immun, 76, 2333, 10.1128/IAI.01515-07 Hu, 2006, Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis, Int J Tuberc Lung Dis, 10, 317 Voskuil, 2004, Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy, Tuberculosis, 84, 218, 10.1016/j.tube.2004.02.003 Wayne, 1996, An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence, Infect Immun, 64, 2062, 10.1128/IAI.64.6.2062-2069.1996 Rustad, 2008, The enduring hypoxic response of Mycobacterium tuberculosis, PLoS One, 3, 10.1371/journal.pone.0001502 Bacon, 2004, The influence of reduced oxygen availability on pathogenicity and gene expression in Mycobacterium tuberculosis, Tuberculosis, 84, 205, 10.1016/j.tube.2003.12.011 Taneja, 2007, Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis, J Antimicrob Chemother, 60, 288, 10.1093/jac/dkm207 Khan, 2008, A simple whole cell based high throughput screening protocol using Mycobacterium bovis BCG for inhibitors against dormant and active tubercle bacilli, J Microbiol Methods, 73, 62, 10.1016/j.mimet.2008.01.015 Voskuil, 2003, Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program, J Exp Med, 198, 705, 10.1084/jem.20030205 Ohno, 2003, The effects of reactive nitrogen intermediates on gene expression in Mycobacterium tuberculosis, Cell Microbiol, 5, 637, 10.1046/j.1462-5822.2003.00307.x Schnappinger, 2003, Transcriptional adaptation of Mycobacterium tuberculosis within macrophages, J Exp Med, 198, 693, 10.1084/jem.20030846 Shiloh, 2008, Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection, Cell Host Microbe, 3, 323, 10.1016/j.chom.2008.03.007 Kumar, 2008, Heme oxygenase-1-derived carbon monoxide induces the Mycobacterium tuberculosis dormancy regulon, J Biol Chem, 283, 18032, 10.1074/jbc.M802274200 Nyka, 1974, Studies on the effect of starvation on mycobacteria, Infect Immun, 9, 843, 10.1128/IAI.9.5.843-850.1974 Betts, 2002, Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling, Mol Microbiol, 43, 717, 10.1046/j.1365-2958.2002.02779.x Yuan, 1998, The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages, Proc Natl Acad Sci U S A, 95, 9578, 10.1073/pnas.95.16.9578 Dubnau, 2002, Font{á}n P. Mycobacterium tuberculosis genes induced during infection of human macrophages, Infect Immun, 70, 2787, 10.1128/IAI.70.6.2787-2795.2002 Garbe, 1999, Response to reactive nitrogen intermediates in Mycobacterium tuberculosis: induction of the 16-kilodalton α-crystallin homolog by exposure to nitric oxide donors, Infect Immun, 67, 460, 10.1128/IAI.67.1.460-465.1999 Gengenbacher, 2010, Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability, Microbiology, 156, 81, 10.1099/mic.0.033084-0 Hampshire, 2004, Stationary phase gene expression of Mycobacterium tuberculosis following a progressive nutrient depletion: a model for persistent organisms?, Tuberculosis, 84, 228, 10.1016/j.tube.2003.12.010 Rodriguez, 2014, Metallobiology of tuberculosis, Microbiol Spectr, 2 Schaer, 2006, CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin, Blood, 107, 373, 10.1182/blood-2005-03-1014 Saiga, 2008, Lipocalin 2-dependent inhibition of mycobacterial growth in alveolar epithelium, J Immunol, 181, 8521, 10.4049/jimmunol.181.12.8521 Kurthkoti, 2017, The capacity of Mycobacterium tuberculosis to survive iron starvation might enable it to persist in iron-deprived microenvironments of human granulomas, mBio, 8, 10.1128/mBio.01092-17 Park, 2003, Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis, Mol Microbiol, 48, 833, 10.1046/j.1365-2958.2003.03474.x Voskuil, 2004, Mycobacterium tuberculosis gene expression during environmental conditions associated with latency, Tuberculosis, 138, 10.1016/j.tube.2003.12.008 Pandey, 2008, Mycobacterial persistence requires the utilization of host cholesterol, Proc Natl Acad Sci U S A, 105, 4376, 10.1073/pnas.0711159105 Draper, 2005, Ions and RNA foldings, Annu Rev Biophys Biomol Struct, 34, 221, 10.1146/annurev.biophys.34.040204.144511 Smith, 1998, Microbial magnesium transport : unusual transporters searching for identity, Mol Microbiol, 28, 217, 10.1046/j.1365-2958.1998.00810.x Buchmeier, 2000, A parallel intraphagosomal survival strategy shared by Mycobacterium tuberculosis and Salmonella enterica, Mol Microbiol, 35, 1375, 10.1046/j.1365-2958.2000.01797.x Goodsmith, 2015, Disruption of an M. tuberculosis membrane protein causes a agnesium-dependent cell division defect and failure to persist in mice, PLoS Pathog, 1 Vandal, 2009, A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis, Nat Med, 14, 849, 10.1038/nm.1795 Rowland, 2012, Resistance mechanisms of Mycobacterium tuberculosis against phagosomal copper overload, Tuberculosis (Edinb), 92, 202, 10.1016/j.tube.2011.12.006 Shi, 2015, Copper homeostasis in Mycobacterium tuberculosis, Metall, 7, 929, 10.1039/C4MT00305E Wagner, 2005, Elemental analysis of Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium smegmatis-containing phagosomes indicates pathogen-induced microenvironments within the host cell's endosomal system, J Immunol, 174, 1491, 10.4049/jimmunol.174.3.1491 Ward, 2008, The global responses of Mycobacterium tuberculosis to physiological levels of copper, J Bacteriol, 190, 2939, 10.1128/JB.01847-07 Salina, 2014, Potassium availability triggers Mycobacterium tuberculosis transition to, and resuscitation from, non-culturable (dormant) states, Open Biol, 4, 140106, 10.1098/rsob.140106 Rohde, 2007, Mycobacterium tuberculosis and the environment within the phagosome, Immunol Rev, 219, 37, 10.1111/j.1600-065X.2007.00547.x Deb, 2009, A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen, PLoS One, 4, 10.1371/journal.pone.0006077 Taneja, 2010, Mycobacterium tuberculosis transcriptional adaptation, growth arrest and dormancy phenotype development is triggered by vitamin C, PLoS One, 5, 18, 10.1371/journal.pone.0010860 Kudykina, 2011 Sikri, 2015, The pleiotropic transcriptional response of Mycobacterium tuberculosis to vitamin C is robust and overlaps with the bacterial response to multiple intracellular stresses, Microbiology, 161, 739, 10.1099/mic.0.000049 Rifat, 2009, Phosphate Depletion: a novel trigger for Mycobacterium tuberculosis persistence, J Infect Dis, 200, 1126, 10.1086/605700 Peyron, 2008, Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence, PLoS Pathog, 4, 1, 10.1371/journal.ppat.1000204 Rodríguez, 2014, Global adaptation to a lipid environment triggers the dormancy-related phenotype of Mycobacterium tuberculosis, mBio, 5, 10.1128/mBio.01125-14 Betts, 2003, Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis, Antimicrob Agents Chemother, 47, 2903, 10.1128/AAC.47.9.2903-2913.2003 Boshoff, 2004, The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. Novel insights into drug mechanisms of action, J Biol Chem, 279, 40174, 10.1074/jbc.M406796200 Keren, 2011, Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters, mBio, 2, 10.1128/mBio.00100-11 Wakamoto, 2013, Dynamic persistence of antibiotic-stressed mycobacteria, Science, 339, 91, 10.1126/science.1229858 Blaser, 1985, Two compartment kinetic model with multiple artificial capillary units, J Antimicrob Chemother, 15, 131, 10.1093/jac/15.suppl_A.131 Gumbo, 2005, Pharmacodynamic evidence that ciprofloxacin failure against tuberculosis is not due to poor microbial kill but to rapid emergence of resistance, Antimicrob Agents Chemother, 49, 3178, 10.1128/AAC.49.8.3178-3181.2005 Gumbo, 2009, Pharmacokinetics-Pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect : a paradigm for faster assessment of new antituberculosis drugs, Antimicrob Agents Chemother, 53, 3197, 10.1128/AAC.01681-08 Heifets, 1992, Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial population, Am Rev Respir Dis, 145, 1223, 10.1164/ajrccm/145.5.1223 Drusano GL, Sgambati N, Eichas A, Brown D, Kulawy R, Louie A. Exposure-response of Mycobacterium tuberculosis ( Mtb) in the state of Wayne-Hayes level II anaerobiosis to moxifloxacin (M). In: 52nd interscience conference of antimicrobial agents and chemotherapy. (ICAAC), San Francisco, CA, 9–12 September 2012. Sala, 2010, Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis, Antimicrob Agents Chemother, 54, 4150, 10.1128/AAC.00821-10 Hashimoto, 1955, Kekkaku, 30, 4 Honore, 1995, Novel mutation in 16S rRNA associated with streptomycin dependence in Mycobacterium tuberculosis, Antimicrob Agents Chemother, 39, 769, 10.1128/AAC.39.3.769 Muttucumaru, 2004, Gene expression profile of Mycobacterium tuberculosis in a non-replicating state, Tuberculosis, 84, 239, 10.1016/j.tube.2003.12.006 Benjak, 2016, Genomic and transcriptomic analysis of the streptomycin-dependent Mycobacterium tuberculosis strain 18b, BMC Genomics, 17, 1, 10.1186/s12864-016-2528-2 Balaban, 2004, Bacterial persistence as a phenotypic switch, Science, 305, 1622, 10.1126/science.1099390 Keren, 2004, Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli, J Bacteriol, 186, 8172, 10.1128/JB.186.24.8172-8180.2004 Torrey, 2016, High persister mutants in Mycobacterium tuberculosis, PLoS One, 11, 1, 10.1371/journal.pone.0155127